Earnings Feed
Start Free
REVVITY, INC.·4

Feb 6, 4:05 PM ET

Singh Prahlad R. 4

4 · REVVITY, INC. · Filed Feb 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Revvity CEO Prahlad R. Singh Exercises Options and Sells Shares

What Happened
Prahlad R. Singh (President, Chief Executive Officer and Director) exercised stock options to acquire 25,525 shares at $92.09 per share (cost ≈ $2,350,597) and conducted multiple share dispositions over Feb 4–5, 2026 that generated roughly $2.90M in proceeds. Separately, 3,421 shares were surrendered to cover tax withholding (value ≈ $345,966). Mr. Singh also received grants/awards of restricted stock units totaling 103,443 shares (26,796 + 76,647) reported as acquisitions at $0 (RSUs).

Key Details

  • Transaction dates: Feb 4–5, 2026; Form 4 filed Feb 6, 2026 (timely filing).
  • Option exercise: 25,525 shares exercised at $92.09 (≈ $2.35M cash paid).
  • Cash sales/dispositions (open market & tax withholding): total proceeds ≈ $2.90M, individual weighted-average prices ranged about $98.98–$103.03 across multiple trades.
    • Tax withholding surrender: 3,421 shares @ $101.13 = $345,966 (surrender to satisfy RSU tax) (F2).
    • Market sales: several blocks (1,307; 12,186; 7,885; 3,079; 1,068 shares) at weighted-average prices shown in filing (F5–F9).
  • Grants/awards reported: 26,796 and 76,647 RSUs (reported as acquisitions @ $0); RSUs/options generally vest in three equal annual installments per footnotes (F1, F3, F11).
  • Sales were effected pursuant to a 10b5-1 trading plan adopted Feb 6, 2025 (F4).
  • Shares owned after transaction: not specified in the excerpt — see the Form 4 for total post-transaction holdings.

Context

  • This was essentially an option exercise followed by share sales (common “exercise and sell” pattern). The exercise required cash (~$2.35M) and many of the acquired shares were subsequently sold under a preplanned 10b5-1 program; some shares were surrendered to cover tax withholding on vested RSUs.
  • Grants/RSUs reported here are time‑based awards with multi-year vesting (not immediate open‑market purchases), so the awards themselves do not signal an immediate buy.
  • The presence of a 10b5-1 plan indicates the sales were prearranged; filing appears timely (filed two days after the reported transactions).

For full line‑by‑line details, including exact per‑trade prices and post‑transaction holdings, consult the filed Form 4 (Accession 0001193125-26-041158).

Insider Transaction Report

Form 4
Period: 2026-02-04
REVVITY, INC.RVTY
Singh Prahlad R.
DirectorPlease See Remarks
Transactions
  • Tax Payment

    Common Stock

    [F1][F2]
    2026-02-04$101.13/sh−3,421$345,966→ 93,417 total
  • Award

    Common Stock

    [F3]
    2026-02-04+26,796→ 120,213 total
  • Exercise/Conversion

    Common Stock

    2026-02-05$92.09/sh+25,525$2,350,597→ 145,738 total
  • Sale

    Common Stock

    [F4][F5]
    2026-02-05$99.02/sh−1,307$129,419→ 144,431 total
  • Sale

    Common Stock

    [F4][F6]
    2026-02-05$99.55/sh−12,186$1,213,116→ 132,245 total
  • Sale

    Common Stock

    [F4][F7]
    2026-02-05$100.63/sh−7,885$793,468→ 124,360 total
  • Sale

    Common Stock

    [F4][F8]
    2026-02-05$101.45/sh−3,079$312,365→ 121,281 total
  • Sale

    Common Stock

    [F4][F9]
    2026-02-05$102.52/sh−1,068$109,491→ 120,213 total
  • Award

    NQ Stock Option (right to buy)

    [F11]
    2026-02-04+76,647→ 76,647 total
    Exercise: $103.39Exp: 2033-02-04→ Common Stock (76,647 underlying)
  • Exercise/Conversion

    NQ Stock Option (right to buy)

    [F12]
    2026-02-05−25,525→ 0 total
    Exercise: $92.09Exp: 2026-02-05→ Common Stock (25,525 underlying)
Holdings

  • Common Stock

    [F10]
    (indirect: By Trust)
    46,583
Footnotes (12)
  • [F1]The vesting schedule for the restricted stock unit grant to the Reporting Person included in the Form 4 filed on February 6, 2025 was incorrectly reported due to administrative error. The restricted stock unit grant included in that Form 4 is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.
  • [F10]Securities held in an irrevocable trust for the sole benefit of the Reporting Person's children. The Reporting Person's spouse is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F11]This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.
  • [F12]This option became exercisable in three equal annual installments beginning on February 5, 2020, which was the first anniversary of the date on which the option was granted.
  • [F2]These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 4, 2025, as required by the Reporting Person's Restricted Stock Unit Agreement.
  • [F3]Shares are time-based restricted stock units that are scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.
  • [F4]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 6, 2025.
  • [F5]The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $98.98 to $99.07. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F6]The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $99.10 to $100.08. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F7]The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $100.10 to $101.09. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F8]The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $101.12 to $101.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F9]The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $102.18 to $103.03. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
Signature
John L. Healy (POA on file) for Prahlad R. Singh|2026-02-06

Documents

1 file
  • 4
    ownership.xmlPrimary

    4